ClosedLoop.ai CEO and leadership

Andrew’s executive and entrepreneurial experience spans over 20 years in B2C and B2B, for startups and Fortune 500 companies. Andrew founded and sold three technology companies and today is the CEO and Founder of ClosedLoop.ai.In 2017 Andrew founded his fourth technology company, ClosedLoop.ai - Healthcare’s Data Science Platform. ClosedLoop makes it easy and affordable for healthcare organizations to use data science to improve quality and reduce costs. Prior to founding ClosedLoop, Andrew co-founded the mobile software company Boxer. Boxer developed mobile productivity software for individuals and large corporations. Boxer's flagship email product was downloaded by millions of users and received significant industry praise for its exceptional user interface, including a 2015 Webby Nomination as one of the top 5 productivity applications in the world. Boxer was purchased by VMWare (one of the top 10 largest software companies in the world) in 2015.Prior to Boxer, Andrew co-founded the cyber security firm Ciphent in 2007. Ciphent grew to nearly 100 employees with 1,000 customers by 2010 before being acquired by Accuvant (now Optiv). With a three year growth rate of 8900%, Ciphent was recognized by Inc. Magazine as the #16th Fastest Growing Private Company in the United States. During his tenure as SVP of Services at Accuvant, Andrew oversaw a $50mm, 200 person organization and was responsible for doubling revenues in 18 months. Andrew also served as CEO of Bodkin Consulting Group where he worked with Fortune 500 brands and technology companies to define their interactive marketing strategies. Andrew began his career as a software architect working with NASA, i2 technologies, and the US Marine Corps. Andrew graduated Summa Cum Laude from Virgina Tech with a degree in Management Information Technology. Andrew lives in Austin TX with his wife, two daughters and champion “Dock Dog” Sophie.​​

Dave has over 20 years of experience transitioning advanced technology from academic research labs into successful businesses. His experience includes genome research, pharmaceutical development, health insurance, computer vision, sports analytics, speech recognition, transportation logistics, operations research, real time collaboration, robotics, and financial markets. Dave has been involved in several successful startups as well as consulting and advising both small and large organizations on how to innovate using technology with maximum impact. As part of the Human Genome Project, he was responsible for mapping all known biology onto the newly developed genome sequences. At Bluefin Labs, acquired by Twitter in 2014, he helped the founders recruit a team and go from concept to a launch with the NFL in 13 weeks. At GNS Healthcare, he led the development of their first in class causal machine learning platform.Dave graduated from MIT with a degree in Electrical Engineering and Computer Science and currently lives in Austin, TX.

Carol McCall leads the development of new products at GNS Healthcare and oversees the execution of projects for real world outcomes. Carol is a health actuary with a background in innovation, predictive analytics and health services design. Her specialties are creating novel computational approaches that leverage big data in healthcare. She also designs services and business models that expand on the traditional notions of health, care, community and sustainability. Most recently, Carol served as Chief Innovation Officer at Tenzing Health, a subsidiary of Vanguard Health Systems, where she merged creative analytic approaches with innovations in health services that improved people’s health and dramatically reduced their healthcare costs. Prior to joining Tenzing, Carol led the R&D efforts in Humana’s Innovation Center, where she pioneered using sophisticated analytic techniques to build a portfolio of prediction, knowledge discovery, and simulation models. She also launched Humana’s innovations in personalized medicine and led Humana’s Health Services Research Center (HSRC). Carol also served as Humana’s Chief Information Officer and as VP of Pharmacy Management. Prior to Humana, Carol served as EVP of Managed Care Business Development for Allscripts Healthcare Solutions and as an actuarial consultant for Milliman, an international provider of actuarial services. Carol also helped launch Green Ribbon Health, LLC a Florida-based company creating innovations in health support services for seniors in Tampa, and later served on their board of directors. She served as a member of the National Committee on Vital and Health Statistics, a member of the HSRC’s governing board, and as advisor to the HRP Scientific Program Board. Carol is a member of the American Academy of Actuaries and a Fellow of the Society of Actuaries. She received a B.S. in actuarial science from University of Iowa.

Paul is is Chief Revenue Officer at ClosedLoop.ai, the data science platform for healthcare. Prior to ClosedLoop, Paul spent 15 years in go-to-market leadership roles for top growth-stage technology companies in the domains of enterprise software and AI, such as NetSuite and DataRobot. Paul began his career with Mercer Management Consulting and IBM Business Consulting where he led strategy and growth projects for Fortune 500 clients. Paul graduated summa cum laude from Bowdoin College and received an MBA from the Tuck School of Business at Dartmouth College.

Specialties: software-as-a-service, general management, complex sales, competitive analysis, quantitative analysis, growth strategy, operational assessment and improvement, facilitating senior level presentations and workshops, managing and motivating staff.

Andrew’s executive and entrepreneurial experience spans over 20 years in B2C and B2B, for startups and Fortune 500 companies. Andrew founded and sold three technology companies and today is the CEO and Founder of ClosedLoop.ai.In 2017 Andrew founded his fourth technology company, ClosedLoop.ai - Healthcare’s Data Science Platform. ClosedLoop makes it easy and affordable for healthcare organizations to use data science to improve quality and reduce costs. Prior to founding ClosedLoop, Andrew co-founded the mobile software company Boxer. Boxer developed mobile productivity software for individuals and large corporations. Boxer's flagship email product was downloaded by millions of users and received significant industry praise for its exceptional user interface, including a 2015 Webby Nomination as one of the top 5 productivity applications in the world. Boxer was purchased by VMWare (one of the top 10 largest software companies in the world) in 2015.Prior to Boxer, Andrew co-founded the cyber security firm Ciphent in 2007. Ciphent grew to nearly 100 employees with 1,000 customers by 2010 before being acquired by Accuvant (now Optiv). With a three year growth rate of 8900%, Ciphent was recognized by Inc. Magazine as the #16th Fastest Growing Private Company in the United States. During his tenure as SVP of Services at Accuvant, Andrew oversaw a $50mm, 200 person organization and was responsible for doubling revenues in 18 months. Andrew also served as CEO of Bodkin Consulting Group where he worked with Fortune 500 brands and technology companies to define their interactive marketing strategies. Andrew began his career as a software architect working with NASA, i2 technologies, and the US Marine Corps. Andrew graduated Summa Cum Laude from Virgina Tech with a degree in Management Information Technology. Andrew lives in Austin TX with his wife, two daughters and champion “Dock Dog” Sophie.​​

Dave has over 20 years of experience transitioning advanced technology from academic research labs into successful businesses. His experience includes genome research, pharmaceutical development, health insurance, computer vision, sports analytics, speech recognition, transportation logistics, operations research, real time collaboration, robotics, and financial markets. Dave has been involved in several successful startups as well as consulting and advising both small and large organizations on how to innovate using technology with maximum impact. As part of the Human Genome Project, he was responsible for mapping all known biology onto the newly developed genome sequences. At Bluefin Labs, acquired by Twitter in 2014, he helped the founders recruit a team and go from concept to a launch with the NFL in 13 weeks. At GNS Healthcare, he led the development of their first in class causal machine learning platform.Dave graduated from MIT with a degree in Electrical Engineering and Computer Science and currently lives in Austin, TX.